APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical Freeze-Dried Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radiopharmaceutical Freeze-Dried Products Market Analysis and Forecast 2026-2032

29 December 2025199 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Freeze-Dried Products Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Freeze-Dried Products Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Freeze-Dried Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Freeze-Dried Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Freeze-Dried Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Radiopharmaceutical Freeze-Dried Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Radiopharmaceutical Freeze-Dried Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiopharmaceutical Freeze-Dried Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Radiopharmaceutical Freeze-Dried Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiopharmaceutical Freeze-Dried Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Radiopharmaceutical Freeze-Dried Products include Rosatom, NTP, NRG, IRE and ANSTO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Radiopharmaceutical Freeze-Dried Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiopharmaceutical Freeze-Dried Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Radiopharmaceutical Freeze-Dried Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceutical Freeze-Dried Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiopharmaceutical Freeze-Dried Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radiopharmaceutical Freeze-Dried Products revenue, projected growth trends, production technology, application and end-user industry.

Radiopharmaceutical Freeze-Dried Products Segment by Company

Rosatom

NTP

NRG

IRE

ANSTO

Radiopharmaceutical Freeze-Dried Products Segment by Type

Bone Imaging Kits

Renal (Kidney) Imaging Kits

Cardiac (Heart) Imaging Kits

Others

Radiopharmaceutical Freeze-Dried Products Segment by Application

Hospital

Clinic

Radiopharmaceutical Freeze-Dried Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical Freeze-Dried Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical Freeze-Dried Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical Freeze-Dried Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Radiopharmaceutical Freeze-Dried Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Radiopharmaceutical Freeze-Dried Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Freeze-Dried Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceutical Freeze-Dried Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bone Imaging Kits Major Player Table 3. Renal (Kidney) Imaging Kits Major Player Table 4. Cardiac (Heart) Imaging Kits Major Player Table 5. Others Major Player Table 6. Global Radiopharmaceutical Freeze-Dried Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Radiopharmaceutical Freeze-Dried Products Industry Trends Table 10. Radiopharmaceutical Freeze-Dried Products Industry Drivers Table 11. Radiopharmaceutical Freeze-Dried Products Industry Opportunities and Challenges Table 12. Radiopharmaceutical Freeze-Dried Products Industry Restraints Table 13. Global Radiopharmaceutical Freeze-Dried Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Radiopharmaceutical Freeze-Dried Products Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Radiopharmaceutical Freeze-Dried Products Market Share by Region (2021-2026) Table 16. Global Radiopharmaceutical Freeze-Dried Products Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Radiopharmaceutical Freeze-Dried Products Market Share by Region (2027-2032) Table 18. Global Radiopharmaceutical Freeze-Dried Products Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Players (2021-2026) Table 20. Global Radiopharmaceutical Freeze-Dried Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Radiopharmaceutical Freeze-Dried Products Key Players Headquarters & Area Served Table 22. Global Radiopharmaceutical Freeze-Dried Products Players, Product Type & Application Table 23. Global Radiopharmaceutical Freeze-Dried Products Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Radiopharmaceutical Freeze-Dried Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Radiopharmaceutical Freeze-Dried Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Type (2021-2026) Table 30. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Type (2027-2032) Table 31. Global Radiopharmaceutical Freeze-Dried Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Application (2021-2026) Table 35. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Application (2027-2032) Table 36. Rosatom Company Information Table 37. Rosatom Business Overview Table 38. Rosatom Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Rosatom Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 40. Rosatom Recent Development Table 41. NTP Company Information Table 42. NTP Business Overview Table 43. NTP Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. NTP Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 45. NTP Recent Development Table 46. NRG Company Information Table 47. NRG Business Overview Table 48. NRG Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. NRG Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 50. NRG Recent Development Table 51. IRE Company Information Table 52. IRE Business Overview Table 53. IRE Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. IRE Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 55. IRE Recent Development Table 56. ANSTO Company Information Table 57. ANSTO Business Overview Table 58. ANSTO Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ANSTO Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 60. ANSTO Recent Development Table 61. North America Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 64. North America Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 65. North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026) & (US$ Million) Table 67. North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (US$ Million) & (2027-2032) Table 68. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 69. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 70. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 71. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 72. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026) & (US$ Million) Table 74. Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (US$ Million) & (2027-2032) Table 75. China Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 76. China Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 77. China Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 78. China Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 79. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 80. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 81. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 82. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Region (US$ Million) & (2021-2026) Table 85. Asia Radiopharmaceutical Freeze-Dried Products Revenue by Region (US$ Million) & (2027-2032) Table 86. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026) & (US$ Million) Table 87. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032) & (US$ Million) Table 88. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026) & (US$ Million) Table 89. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032) & (US$ Million) Table 90. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026) & (US$ Million) Table 92. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (US$ Million) & (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Radiopharmaceutical Freeze-Dried Products Image Figure 2. Global Radiopharmaceutical Freeze-Dried Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Freeze-Dried Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bone Imaging Kits Image Figure 5. Renal (Kidney) Imaging Kits Image Figure 6. Cardiac (Heart) Imaging Kits Image Figure 7. Others Image Figure 8. Global Radiopharmaceutical Freeze-Dried Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Radiopharmaceutical Freeze-Dried Products Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Radiopharmaceutical Freeze-Dried Products Market Size (US$ Million) & (2021-2032) Figure 13. Global Radiopharmaceutical Freeze-Dried Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Radiopharmaceutical Freeze-Dried Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Radiopharmaceutical Freeze-Dried Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Type (2021-2032) Figure 20. Global Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Application (2021-2032) Figure 23. North America Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032) Figure 25. North America Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032) Figure 26. North America Radiopharmaceutical Freeze-Dried Products Revenue Share by Country (2021-2032) Figure 27. United States Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032) Figure 32. Europe Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032) Figure 33. Europe Radiopharmaceutical Freeze-Dried Products Revenue Share by Country (2021-2032) Figure 34. Germany Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032) Figure 44. China Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032) Figure 45. Asia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032) Figure 47. Asia Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032) Figure 48. Asia Radiopharmaceutical Freeze-Dried Products Revenue Share by Region (2021-2032) Figure 49. Japan Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032) Figure 57. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032) Figure 58. SAMEA Radiopharmaceutical Freeze-Dried Products Revenue Share by Country (2021-2032) Figure 59. Brazil Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Radiopharmaceutical Freeze-Dried Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Imaging Kits
  • Renal (Kidney) Imaging Kits
  • Cardiac (Heart) Imaging Kits
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Rosatom
  • NTP
  • NRG
  • IRE
  • ANSTO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiopharmaceutical Freeze-Dried Products Market by Type
  3. 1.2.1 Global Radiopharmaceutical Freeze-Dried Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bone Imaging Kits
  5. 1.2.3 Renal (Kidney) Imaging Kits
  6. 1.2.4 Cardiac (Heart) Imaging Kits
  7. 1.2.5 Others
  8. 1.3 Radiopharmaceutical Freeze-Dried Products Market by Application
  9. 1.3.1 Global Radiopharmaceutical Freeze-Dried Products Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Radiopharmaceutical Freeze-Dried Products Market Dynamics
  1. 2.1 Radiopharmaceutical Freeze-Dried Products Industry Trends
  2. 2.2 Radiopharmaceutical Freeze-Dried Products Industry Drivers
  3. 2.3 Radiopharmaceutical Freeze-Dried Products Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Freeze-Dried Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Radiopharmaceutical Freeze-Dried Products Market Perspective (2021-2032)
  2. 3.2 Global Radiopharmaceutical Freeze-Dried Products Growth Trends by Region
  3. 3.2.1 Global Radiopharmaceutical Freeze-Dried Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiopharmaceutical Freeze-Dried Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Radiopharmaceutical Freeze-Dried Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Radiopharmaceutical Freeze-Dried Products Revenue by Players
  2. 4.1.1 Global Radiopharmaceutical Freeze-Dried Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Radiopharmaceutical Freeze-Dried Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiopharmaceutical Freeze-Dried Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Radiopharmaceutical Freeze-Dried Products Key Players Headquarters & Area Served
  7. 4.4 Global Radiopharmaceutical Freeze-Dried Products Players, Product Type & Application
  8. 4.5 Global Radiopharmaceutical Freeze-Dried Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Radiopharmaceutical Freeze-Dried Products Market CR5 and HHI
  11. 4.6.3 2025 Radiopharmaceutical Freeze-Dried Products Tier 1, Tier 2, and Tier 3
5 Radiopharmaceutical Freeze-Dried Products Market Size by Type
  1. 5.1 Global Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 5.3 Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Type (2021-2032)
6 Radiopharmaceutical Freeze-Dried Products Market Size by Application
  1. 6.1 Global Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  3. 6.3 Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Rosatom
  2. 7.1.1 Rosatom Company Information
  3. 7.1.2 Rosatom Business Overview
  4. 7.1.3 Rosatom Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Rosatom Radiopharmaceutical Freeze-Dried Products Product Portfolio
  6. 7.1.5 Rosatom Recent Developments
  7. 7.2 NTP
  8. 7.2.1 NTP Company Information
  9. 7.2.2 NTP Business Overview
  10. 7.2.3 NTP Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NTP Radiopharmaceutical Freeze-Dried Products Product Portfolio
  12. 7.2.5 NTP Recent Developments
  13. 7.3 NRG
  14. 7.3.1 NRG Company Information
  15. 7.3.2 NRG Business Overview
  16. 7.3.3 NRG Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NRG Radiopharmaceutical Freeze-Dried Products Product Portfolio
  18. 7.3.5 NRG Recent Developments
  19. 7.4 IRE
  20. 7.4.1 IRE Company Information
  21. 7.4.2 IRE Business Overview
  22. 7.4.3 IRE Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IRE Radiopharmaceutical Freeze-Dried Products Product Portfolio
  24. 7.4.5 IRE Recent Developments
  25. 7.5 ANSTO
  26. 7.5.1 ANSTO Company Information
  27. 7.5.2 ANSTO Business Overview
  28. 7.5.3 ANSTO Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ANSTO Radiopharmaceutical Freeze-Dried Products Product Portfolio
  30. 7.5.5 ANSTO Recent Developments
8 North America
  1. 8.1 North America Radiopharmaceutical Freeze-Dried Products Revenue (2021-2032)
  2. 8.2 North America Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032)
  5. 8.3 North America Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032)
  9. 8.5 North America Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Radiopharmaceutical Freeze-Dried Products Revenue by Country
  11. 8.6.1 North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Radiopharmaceutical Freeze-Dried Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Radiopharmaceutical Freeze-Dried Products Revenue (2021-2032)
  2. 9.2 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032)
  5. 9.3 Europe Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032)
  9. 9.5 Europe Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country
  11. 9.6.1 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Radiopharmaceutical Freeze-Dried Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Radiopharmaceutical Freeze-Dried Products Revenue (2021-2032)
  2. 10.2 China Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 10.2.1 China Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026)
  4. 10.2.2 China Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032)
  5. 10.3 China Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032)
  6. 10.4 China Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  7. 10.4.1 China Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026)
  8. 10.4.2 China Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032)
  9. 10.5 China Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiopharmaceutical Freeze-Dried Products Revenue (2021-2032)
  2. 11.2 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032)
  5. 11.3 Asia Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032)
  9. 11.5 Asia Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Country
  11. 11.6.1 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Radiopharmaceutical Freeze-Dried Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue (2021-2032)
  2. 12.2 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country
  11. 12.6.1 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Radiopharmaceutical Freeze-Dried Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst